Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity.
Nadar RA, Farbod K, der Schilden KC, Schlatt L, Crone B, Asokan N, Curci A, Brand M, Bornhaeuser M, Iafisco M, Margiotta N, Karst U, Heskamp S, Boerman OC, van den Beucken JJJP, Leeuwenburgh SCG.
Nadar RA, et al.
Sci Rep. 2020 Apr 3;10(1):5889. doi: 10.1038/s41598-020-62039-2.
Sci Rep. 2020.
PMID: 32246003
Free PMC article.